Malabsorption

Also known as: Intestinal malabsorption, unspecified / Malabsorption syndrome / Syndrome malabsorption / Malabsorption Syndromes / Malabsorption syndrome (disorder) / Intestinal malabsorption / Unspecified intestinal malabsorption / Intestinal malabsorption (disorder)

Drug	Drug Name	Drug Description
DB01436	Alfacalcidol	A vitamin D analogue used for the management of hypocalcemia, secondary hyperparathyroidism, and osteodystrophy in patients with chronic renal failure, as well as some types of rickets and osteomalacia.
DB12208	Iron isomaltoside 1000	Iron isomaltoside 1000 is under investigation in Iron Deficiency Anaemia. Iron isomaltoside 1000 has been investigated for the treatment and basic science of Anemia, Gastric Cancer, Esophageal Cancer, Chronic Kidney...

Drug	Drug Name	Target	Type
DB01436	Alfacalcidol	Vitamin D-binding protein	carrier
DB01436	Alfacalcidol	Vitamin D3 receptor	target
DB01436	Alfacalcidol	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	target
DB01436	Alfacalcidol	Retinoic acid receptor RXR-alpha	target
DB01436	Alfacalcidol	Alpha globin	carrier

Drug	Drug Name	Phase	Status	Count
DB00916	Metronidazole	Not Available	Completed	1